跳至主要内容
临床试验/NCT01533038
NCT01533038已完成不适用

BPH-6: A UroLift® System Post Market Multi-Center Randomized Study

NeoTract, Inc.14 个研究点 分布在 3 个国家目标入组 80 人开始时间: 2012年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
14
主要终点
Responder Analysis: A Subject is a Responder at the 12 Month Follow-up Time Point if All 6 Thresholds of the BPH-6 Endpoint Are Met

研究概览

简要总结

The purpose of this study is to compare the UroLift System Treatment to Transurethral Resection of the Prostate (TURP) in improving a patient's overall quality of life, while evaluating healthcare expenditures associated with each therapy.

详细描述

The study is a prospective, consecutive, multi-center, 1:1 randomized study (UroLift System:TURP). The study is intended to be conducted at up to 20 different centers in Europe and Canada to enroll up to 100 subjects.

Subject follow-up visits are at 2 weeks, 1, 3, 6, 12 and 24 months for all subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men >50 years old with moderate-severe BPH

排除标准

  • Size, width of prostate
  • Other medical condition or co-morbidity contraindicative for TURP or UroLift

研究组 & 干预措施

UroLift System

Active Comparator

UroLift System procedure

干预措施: UroLift System (Device)

Transurethral Resection of the Prostate

Active Comparator

Transurethral Resection of the Prostate surgery

干预措施: Transurethral Resection of the Prostate (Procedure)

结局指标

主要结局

Responder Analysis: A Subject is a Responder at the 12 Month Follow-up Time Point if All 6 Thresholds of the BPH-6 Endpoint Are Met

时间窗: Month 12

1. LUTS: ≥ 30% reduction in IPSS compared to baseline 2. Recovery Experience: Return to pre-operative activity levels by 1 month 3. Erectile function: Less than 6-point reduction in SHIM compared to baseline. 4. Ejaculatory function: Response on MSHQ-EjD that indicates emission of semen. This excludes the response "Could not ejaculate" 5. Continence: ISI score of 4 points or less at all follow-up time points 6. Safety: No procedure-related adverse event greater than Grade I on the Clavien-Dindo classification system modified for TURP at any time during procedure or follow up.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

BPH-6: Comparison of the UroLift System to TURP for... | 临床试验